Neuberger Berman Group’s Krystal Biotech KRYS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-45,246
| Closed | -$2.35M | – | 1920 |
|
|
2021
Q3 | $2.35M | Buy |
45,246
+583
| +1% | +$30.3K | ﹤0.01% | 1128 |
|
|
2021
Q2 | $3.03M | Buy |
44,663
+603
| +1% | +$41K | ﹤0.01% | 1085 |
|
|
2021
Q1 | $3.39M | Sell |
44,060
-6,940
| -14% | -$535K | ﹤0.01% | 1040 |
|
|
2020
Q4 | $3.06M | Hold |
51,000
| – | – | ﹤0.01% | 1028 |
|
|
2020
Q3 | $2.2M | Buy |
51,000
+8,000
| +19% | +$344K | ﹤0.01% | 1046 |
|
|
2020
Q2 | $1.78M | Buy |
43,000
+18,000
| +72% | +$746K | ﹤0.01% | 1023 |
|
|
2020
Q1 | $1.08M | Sell |
25,000
-15,600
| -38% | -$675K | ﹤0.01% | 1079 |
|
|
2019
Q4 | $2.25M | Hold |
40,600
| – | – | ﹤0.01% | 1009 |
|
|
2019
Q3 | $1.41M | Buy |
40,600
+24,800
| +157% | +$861K | ﹤0.01% | 1078 |
|
|
2019
Q2 | $636K | Buy |
15,800
+6,300
| +66% | +$254K | ﹤0.01% | 1241 |
|
|
2019
Q1 | $313K | Buy |
+9,500
| New | +$313K | ﹤0.01% | 1350 |
|